Sunday, September 30, 2018 10:43:18 PM
The CBD content may be 98% pure CBD, but Epidiolex is described on Google Patents as not just containing CBD, because CBD by itself is unpatentable since it's a plant extract or an isolate. The CBD may be 98% pure, but Epidiolex is not 98% CBD. There is a difference:
Source:
Google Patents: Use of cannabidiol in the treatment of epilepsy
---------------------------------------------------------------------------
Source 2:
To Patent or Not To Patent: Are Natural Products Off the Table?
---------------------------------------------------------------------------
My Take:
GWPH didn't gain a patent on CBD like they would have you believe. They gained a patent on a concoction that contains CBD that is 98% pure, yet Epidiolex is not 98% CBD! Read the patent yourself. Initial cost estimates for the use of Epidiolex is $2,500 to $5,000 per month. A bottle from CVSI only costs around $50.
You can't make this stuff up! This is another reason why hemp CBD extracts won't be condemned to the Schedule V fate of Epidiolex.
PS:
Why CVSI isn't breaking the law
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM